Allison Lin, MD is an addiction psychiatrist and Assistant Professor in the Department of Psychiatry as well as Research Scientist at the VA Ann Arbor Healthcare System. Dr. Lin is also Director of the U-M Addiction Psychiatry Fellowship Program, President-elect of the Michigan Society of Addiction Medicine, Co-Director of the Michigan Opioid Collaborative and American Academy of Addiction Psychiatry Research Committee Chair. Her research is informed by her clinical work treating patients with addiction and recognizing the potential for healthcare systems to help address this major public health crisis. Her research focuses on identifying actionable contributors, gaps and disparities in access and quality of addiction care using large healthcare datasets and developing new interventions and models of care, including through use of telehealth, to improve reach and delivery of evidence-based care to patients
Areas of Interest
- Developing and testing telehealth-delivered interventions for patients with substance use disorders
- Using large healthcare datasets to identify disparities in substance use disorder treatment access and quality of care to determine priorities for interventions.
- Determining and intervening on overdose risk factors
- Improve care for patients with substance use disorders and comorbid conditions (mental health, chronic pain, etc).
Veterans receiving buprenorphine were more likely to stay on it if they had virtual visits, but phone-based virtual care was especially prominent among those who are Black or lack stable housing.
The Hill cites Dr. Allison Lin's study of the rise in veteran opioid overdose deaths
- Addiction Psychiatry Research & Clinical Fellow, Department of Psychiatry, University of Michigan Medical School
- Adult Psychiatry Residency, Department of Psychiatry, University of Michigan Medical School
- M.D. Yale University School of Medicine
- B.S. in Chemical Engineering and Economics, Massachusetts Institute of Technology